A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia
Part of paid clinical trials in Los Alamitos, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT07061288
- Phase
- PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- KarXT — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia
Key Dates
- Start date
- Sep 3, 2025
- Status verified
- Dec 2025
- Primary completion
- Jun 21, 2027
- Completion
- Oct 15, 2027
Study Design
- Enrollment
- 48 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Administration of KarXT
Primary Outcome Measure
Number of participants with adverse events (AEs) [ Time Frame: Up to 3 weeks ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com8559073286
- First line of the email MUST contain the NCT# and Site#
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Collaborative Neuroscience Research, LLC | Los Alamitos | California | 90720-3118 | David Walling, Site 0001 714-799-7799 |
| Research Centers of America ( Hollywood ) | Hollywood | Florida | 33024 | Edwin Gomez, Site 0005 954-990-7649 |
| Innovative Clinical Research, Inc. | Miami Lakes | Florida | 33016 | Rishi Kakar, Site 0004 786-512-4106 |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | Elyssa Barron, Site 0008 404-881-5800 |
| CenExel iResearch, LLC | Decatur | Georgia | 30030 | Kimball Johnson, Site 0003 312-942-5592 |
| Uptown Research Institute | Chicago | Illinois | 60640 | John Sonnenberg, Site 0002 773-968-9868 |
| Hassman Research Institute Marlton Site | Marlton | New Jersey | 08053 | Elan Cohen, Site 0007 856-452-9901 |
| Community Clinical Research | Austin | Texas | 78754 | David Brown, Site 0006 512-323-2622 |
Find similar trials in Los Alamitos, CA
By condition
By specialty
By research site
Related Studies
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Ocrelizumab for Psychosis by AutoimmunityPHASE1/PHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- Imaging Synapses With [11C] UCB-J in the Human BrainPHASE1 · Recruiting · Davidzon, Guido, M.D. · Palo Alto, California